全文获取类型
收费全文 | 4598篇 |
免费 | 359篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 30篇 |
儿科学 | 139篇 |
妇产科学 | 50篇 |
基础医学 | 556篇 |
口腔科学 | 32篇 |
临床医学 | 616篇 |
内科学 | 925篇 |
皮肤病学 | 43篇 |
神经病学 | 389篇 |
特种医学 | 160篇 |
外科学 | 991篇 |
综合类 | 72篇 |
一般理论 | 5篇 |
预防医学 | 368篇 |
眼科学 | 94篇 |
药学 | 249篇 |
中国医学 | 4篇 |
肿瘤学 | 246篇 |
出版年
2023年 | 43篇 |
2022年 | 89篇 |
2021年 | 218篇 |
2020年 | 83篇 |
2019年 | 157篇 |
2018年 | 175篇 |
2017年 | 136篇 |
2016年 | 142篇 |
2015年 | 182篇 |
2014年 | 260篇 |
2013年 | 288篇 |
2012年 | 382篇 |
2011年 | 386篇 |
2010年 | 190篇 |
2009年 | 175篇 |
2008年 | 276篇 |
2007年 | 253篇 |
2006年 | 227篇 |
2005年 | 227篇 |
2004年 | 200篇 |
2003年 | 194篇 |
2002年 | 181篇 |
2001年 | 17篇 |
2000年 | 15篇 |
1999年 | 20篇 |
1998年 | 25篇 |
1997年 | 14篇 |
1996年 | 20篇 |
1995年 | 13篇 |
1994年 | 10篇 |
1993年 | 9篇 |
1992年 | 9篇 |
1991年 | 10篇 |
1989年 | 10篇 |
1987年 | 13篇 |
1986年 | 10篇 |
1983年 | 12篇 |
1982年 | 17篇 |
1981年 | 13篇 |
1980年 | 16篇 |
1979年 | 20篇 |
1978年 | 19篇 |
1977年 | 13篇 |
1976年 | 12篇 |
1975年 | 12篇 |
1973年 | 9篇 |
1972年 | 16篇 |
1971年 | 10篇 |
1964年 | 9篇 |
1940年 | 9篇 |
排序方式: 共有4969条查询结果,搜索用时 31 毫秒
31.
William C. Daly Paul K.J. Han Matthew Hayn Stephen T. Ryan Moritz H. Hansen Joshua P. Linscott Quoc-Dien Trinh Jesse D. Sammon 《Urologic oncology》2021,39(3):192.e15-192.e20
Introduction and objectiveResearch on the utility of meditative and mind-body (MB) practices has increased dramatically in the last two decades and both have been suggested as useful adjuncts in coping with stressors associated with cancer survivorship. There exists little data on use among genitourinary (GU) cancer survivors. This study seeks to describe meditative and MB utilization among GU cancer survivors.MethodsAnalysis of data from the 2012 and 2017 National Health Interview Survey was conducted. Patients aged 40 and older reporting a history of any cancer diagnosis (including 3 GU cancers) were included in the analysis. We explored questions about meditative and MB practices in the past 12 months. Complex Samples Logistic regression was performed to compare the relationship between cancer status and use of these practices.ResultsSelf-reported meditative practices were more prevalent in 2017 (17%) than in 2012 (5%). Patients who self-reported a cancer diagnosis of any kind were significantly more likely to utilize meditative practices. Patients with kidney cancer were significantly more likely to meditate and trended towards higher MB utilization. In contrast, bladder cancer patients were less likely to meditate and use MB practices. Increases in meditation were greater than those seen for MB in all groups.ConclusionsMeditative and MB practices increased in prevalence between 2012 and 2017 with notable heterogeneity between cancer types. Given the potential benefit, more broad incorporation into survivorship programs may be warranted. Future work should explore the significance of this heterogeneity and the utility of these practices to patients with urologic malignancy. 相似文献
32.
Anne M. Huml John R. Sedor Emilio Poggio Rachel E. Patzer Jesse D. Schold 《American journal of transplantation》2021,21(1):32-36
Disparities that affect equity in access to kidney transplantation for patients with kidney failure have been well described. Many robust clinical trials have tested the effectiveness of interventions to reduce disparities and equilibrate access to kidney transplantation. Moreover, policy changes have been enacted to achieve the same aims. Despite these efforts, rates of kidney transplant waitlisting within the first year of end-stage kidney disease have remained unchanged over the past 2 decades, while incident rates of end-stage kidney disease have climbed. Because prior interventions have not durably increased transplant access, disruptive change is clearly needed. The Advancing American Kidney Health Executive Order sets bold goals to transform kidney care for patients and caregivers. In this spirit, we discuss an Opt-Out for Transplant Referral Model as a compelling solution to improve equity in access to kidney transplantation. 相似文献
33.
Wayne M. Tsuang Susana Arrigain Rocio Lopez Marie Budev Jesse D. Schold 《American journal of transplantation》2021,21(1):272-280
There is a broad range of patient travel distances to reach a lung transplant hospital in the United States. Whether patient travel distance is associated with waitlist outcomes is unknown. We present a cohort study of patients listed between January 1, 2006 and May 31, 2017 using the Scientific Registry of Transplant Recipients. Travel distance was measured from the patient's permanent zip code to the transplant hospital using shared access signature URL access to Google Maps, and assessed using multivariable competing risk regression models. There were 22 958 patients who met inclusion criteria. Median travel distance was 69.7 miles. Among patients who traveled > 60 miles, 41.2% bypassed a closer hospital and sought listing at a more distant hospital. In the adjusted models, when compared to patients who traveled ≤60 miles, patients who traveled >360 miles had a 27% lower subhazard ratio (SHR) for waitlist removal (SHR 0.73, 95% confidence interval [CI]: 0.60, 0.89, P = .002), 16% lower subhazard for waitlist death (SHR 0.84; 95% CI 0.73-0.95, P = .07), and 13% increased likelihood for transplant (SHR 1.13, 95% CI: 1.07, 1.20, P < .001). Many patients bypassed the nearest transplant hospital, and longer patient travel distance was associated with favorable waitlist outcomes. 相似文献
34.
35.
Emilio D. Poggio Joshua J. Augustine Susana Arrigain Daniel C. Brennan Jesse D. Schold 《American journal of transplantation》2021,21(8):2824-2832
Current short-term kidney post–transplant survival rates are excellent, but longer-term outcomes have historically been unchanged. This study used data from the national Scientific Registry of Transplant Recipients (SRTR) and evaluated 1-year and 5-year graft survival and half-lives for kidney transplant recipients in the US. All adult (≥18 years) solitary kidney transplants (n = 331,216) from 1995 to 2017 were included in the analysis. Mean age was 49.4 years (SD +/-13.7), 60% male, and 25% Black. The overall (deceased and living donor) adjusted hazard of graft failure steadily decreased from 0.89 (95%CI: 0.88, 0.91) in era 2000–2004 to 0.46 (95%CI: 0.45, 0.47) for era 2014–2017 (1995–1999 as reference). Improvements in adjusted hazards of graft failure were more favorable for Blacks, diabetics and older recipients. Median survival for deceased donor transplants increased from 8.2 years in era 1995–1999 to an estimated 11.7 years in the most recent era. Living kidney donor transplant median survival increased from 12.1 years in 1995–1999 to an estimated 19.2 years for transplants in 2014–2017. In conclusion, these data show continuous improvement in long-term outcomes with more notable improvement among higher-risk subgroups, suggesting a narrowing in the gap for those disadvantaged after transplantation. 相似文献
36.
37.
38.
39.
Mohsen Shahsavari Gholam A. Peyman Michael R. Niesman Michael V. Miceli Jesse Jaynes 《International ophthalmology》1995,19(1):29-34
An investigation was undertaken to determine the toxicity of an intravitreal injection of a novel peptide drug, Shiva-1, in rabbits. The drug, a synthetic peptide modeled after lytic peptides secreted by certain insects, has antiproliferative and antibacterial properties. Initial in vitro experiments showed that the drug, at a concentration of 100 M, was toxic to both Y-79 retinoblastoma cells and human retinal pigment epithelial cells. A wide range of doses (6–1200 g) was injected into the rabbit vitreous in an attempt to determine the maximum tolerated dose. Retinal toxicity was evaluated clinically, by electroretinography, and by light microscopy. Some localized toxicity was evident at 200 g; all doses of 240 g and above were toxic. While the drug appears to exhibit a narrow range between effective and toxic doses, the results suggest that this and other peptides of similar design merit further investigation for the treatment of proliferative and infectious diseases of the eye.Supported in part by U.S. Public Health Service grants EY07541 and EY02377 from the National Eye Institute, the National Institutes of Health Services, Bethesda, MD, USA 相似文献
40.
Jesse Salmeron Patrick J. Gannon Keith E. Blackwell Christopher M. Shaari Mark L. Urken 《The Laryngoscope》1998,108(6):849-853
Objective: To determine the perfusion territories of the superior and inferior thyroid arteries in humans. Tracheal transplantation is a potential option for management of long-segment tracheal stenosis. However, the maximum length of vascularized trachea that can be reliably transplanted has not been established. Study Design: The tracheal vascular territory of individual superior and inferior thyroid arteries was determined separately in 10 humans postmortem. Methods: India ink was infused unilaterally under controlled pressure into the superior (n = 5) and inferior (n = 5) thyroid arteries of cadaveric tracheas. Tracheas were sectioned longitudinally and the caudalmost extent of mucosal dye staining was determined via microscopic assessment. Results: The tracheal perfusion territory of the superior thyroid artery was two to five rings (1.7 ± 0.5 cm) and the inferior thyroid artery, nine to 13 rings (6.5 ± 1.1 cm). In both cases, the tracheal mucosa on the contralateral side was stained to the same caudal level. Conclusions: The inferior thyroid artery was shown to perfuse the trachea maximally to the 13th ring (8.1 cm). As such, the unilateral inferior thyroid artery would serve as a suitable vascular component for long-segment tracheal transplantation in humans. 相似文献